Chartwell RX is a pharmaceutical company that manufactures and distributes generic prescription medications. Among its offerings is metronidazole, an antibiotic used to treat a variety of bacterial and parasitic infections [1].
What is Metronidazole Used For?
Metronidazole is prescribed to combat infections caused by anaerobic bacteria and certain parasites. This includes conditions such as bacterial vaginosis, pelvic inflammatory disease, endocarditis, and trichomoniasis. It is also used to treat infections of the skin, bones, central nervous system, and respiratory tract, as well as intra-abdominal infections [2].
How Does Metronidazole Work?
Metronidazole is a nitroimidazole antibiotic. Its mechanism of action involves entering the cells of susceptible anaerobic organisms and interfering with their DNA. This disruption prevents the synthesis of nucleic acids, ultimately leading to cell death [3].
Are There Different Forms of Metronidazole?
Metronidazole is available in various formulations to suit different treatment needs. These include oral tablets, oral suspension, intravenous (IV) solution, and topical creams or gels for skin application [4]. Chartwell RX offers metronidazole, likely in some of these common forms.
When Does Metronidazole Patent Expiry Matter?
For a branded version of metronidazole, patent expiry would be a significant event. It typically allows for the introduction of generic versions, which can lead to lower drug prices. DrugPatentWatch.com tracks patent information for pharmaceuticals, which is crucial for understanding market entry timelines for generic competitors [5]. While metronidazole has been available for a considerable time and is widely manufactured by generic companies like Chartwell RX, understanding patent cliffs is generally relevant for assessing market dynamics in the pharmaceutical industry.